Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2020

Jul 10, 2020

SELL
$8.05 - $14.21 $96 - $170
-12 Closed
0 $0
Q1 2020

Apr 09, 2020

SELL
$6.8 - $14.66 $353 - $762
-52 Reduced 81.25%
12 $0
Q4 2019

Jan 10, 2020

BUY
$12.82 - $16.85 $435 - $572
34 Added 113.33%
64 $0
Q3 2019

Oct 25, 2019

BUY
$16.31 - $28.29 $326 - $565
20 Added 200.0%
30 $0
Q2 2019

Jul 24, 2019

BUY
$19.18 - $27.88 $191 - $278
10 New
10 $0

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $215M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.